1
Alan J Korman, Edward L Halk, Nils Lonberg, Yashwant M Deo, Tibor P Keler: Human CTLA-4 antibodies. Medarex, Darby & Darby, January 10, 2006: US06984720 (70 worldwide citation)

The present invention provides human sequence antibodies against CTLA-4 and methods of treating human diseases, infections and other conditions using these antibodies.


2
Thomas Andrew Davis, Tibor P Keler, Robert F Graziano, Alan J Korman: Methods of treatment using CTLA-4 antibodies. Medarex, Baker Botts L, November 18, 2008: US07452535 (18 worldwide citation)

The present invention provides method of treatment using human sequence antibodies against human CTLA-4. In particular, methods of treating cancer are provided.


3
Alan J Korman, Edward L Halk, Nils Lonberg, Yashwant M Deo, Tibor P Keler: Human CTLA-4 antibodies and their uses. Medarex, Baker Botts, October 20, 2009: US07605238 (16 worldwide citation)

The present invention provides human sequence antibodies against human CTLA-4 and methods of treating human diseases, infections and other conditions using these antibodies.


4
Alan J Korman, Edward L Halk, Nils Lonberg, Yashwant M Deo, Tibor P Keler: Human CTLA-4 antibodies and their uses. Medarex, Baker Botts L, September 13, 2011: US08017114 (4 worldwide citation)

The present invention provides novel human sequence antibodies against human CTLA-4 and methods of treating human diseases, infections and other conditions using these antibodies.


5
Thomas Andrew Davis, Tibor P Keler, Robert F Graziano, Alan J Korman: Methods of treatment using CTLA-4 antibodies. Medarex, Baker Botts L, March 27, 2012: US08142778 (2 worldwide citation)

The present invention provides method of treatment using human sequence antibodies against human CTLA-4 linked to a cytotoxic agent. In particular, methods of treating cancer and autoimmune disease are provided.


6
Alan J Korman, Edward L Halk, Nils Lonberg, Yashwant M Deo, Tibor P Keler: Human CTLA-4 antibodies and their uses. Medarex, Baker Botts L, November 27, 2012: US08318916 (1 worldwide citation)

The present invention provides novel human sequence antibodies against human CTLA-4 and methods of treating human diseases, infections and other conditions using these antibodies.


7
Thomas Andrew Davis, Tibor P Keler, Robert F Graziano, Alan J Korman: Methods of treatment using CTLA-4 antibodies. Medarex, Darby & Darby PC, January 8, 2004: US20040005318-A1

The present invention provides method of treatment using human sequence antibodies against human CTLA-4. In particular, methods of treating cancer are provided.


8
Alan J Korman, Edward L Halk, Nils Lonberg, Yashwant M Deo, Tibor P Keler: Human CTLA-4 Antibodies and Their Uses. Medarex, Baker Botts, February 25, 2010: US20100047244-A1

The present invention provides novel human sequence antibodies against human CTLA-4 and methods of treating human diseases, infections and other conditions using these antibodies.


9
Thomas Andrew Davis, Tibor P Keler, Robert F Graziano, Alan J Korman: Methods Of Treatment Using CTLA-4 Antibodies. Medarex, Baker Botts, May 7, 2009: US20090117037-A1

The present invention provides method of treatment using human sequence antibodies against human CTLA-4 linked to a cytotoxic agent. In particular, methods of treating cancer and autoimmune disease are provided.


10
Alan J Korman, Edward L Halk, Nils Lonberg, Yashwant M Deo, Tibor P Keler: Human CTLA-4 Antibodies And Their Uses. December 1, 2011: US20110296546-A1

The present invention provides novel human sequence antibodies against human CTLA-4 and methods of treating human diseases, infections and other conditions using these antibodies.